Hide
Additional posters at ACMG describe ongoing studies designed to further examine the use of KUVAN® for PKU, with endpoints of neuropsychiatric effects and long-term safety in children
NOVATO, Calif., March 18, 2011 /PRNewswire/ — BioMarin Pharmaceutical
Read More...
Read the complete post at http://kiddieyap.com/2011/03/first-of-its-kind-study-suggests-importance-of-routine-mental-health-screening-in-the-care-of-patients-suffering-from-genetic-disease-pku/
Posted
Mar 18 2011, 10:49 PM
by
Kiddie Yaps